Free Submission Public Relations &
Deutsch English


Recent Study: Celgene Corporation - SWOT, Strategy and Corporate Finance Report

Print article Print article
2013-02-03 17:32:23 - Recently published research from MarketLine, "Celgene Corporation - SWOT, Strategy and Corporate Finance Report", is now available at Fast Market Research

Celgene Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.


* Detailed information on Celgene Corporation required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
* An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Celgene Corporation

Intelligence on Celgene Corporationnv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Celgene Corporation, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..


Celgene Corporation (Celgene or 'the company an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. The company is headquartered in Summit, New Jersey, and employed 4,460 people as of December 31, 2011. The company recorded revenues of $4,842.1 million during the financial year ended December 2011 (FY2011), an increase of 33.5% over FY2010. The increase in revenues was primarily due to the company's continuing expansion into international markets, growth of Revlimid and Vidaza in both the US and international markets and the inclusion of a full year's sales of Abraxane in FY2011.The operating profit of the company was $1,442.8 million in FY2011, an increase of 45.8% over FY2010. The net profit was $1,318.2 million in FY2011, an increase of 49.7% over FY2010.
Reasons to Purchase:

* Gain understanding of Celgene Corporation and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Celgene Corporation as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Celgene Corporation's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Celgene Corporation: Company Overview
Celgene Corporation: Overview and Key Facts
Celgene Corporation: Overview
Celgene Corporation: Key Facts
Celgene Corporation: Key Employees
Celgene Corporation: Key Employee Biographies
Celgene Corporation: Major Products and Services
Celgene Corporation: Company History
Celgene Corporation: Management Statement
Celgene Corporation: Locations and Subsidiaries
Celgene Corporation: Key Competitors
Celgene Corporation: Company Analysis
Celgene Corporation: Business Description
Celgene Corporation: SWOT Analysis
Celgene Corporation: SWOT Overview
Celgene Corporation: Strengths
Celgene Corporation: Weaknesses
Celgene Corporation: Opportunities
Celgene Corporation: Threats
Celgene Corporation: Corporate Financial Deals Activity
Celgene Corporation: Financial Deals Overview
Celgene Corporation: Targets and Partners
Celgene Corporation: Top Deals 2008 - 2012YTD*
Celgene Corporation: Advisors
Celgene Corporation: Top Legal Advisors
Celgene Corporation: Top Financial Advisors
Celgene Corporation: Mergers and Acquisitions
Celgene Corporation: Corporate Venturing
Celgene Corporation: Partnership
Celgene Corporation: Divestments
Celgene Corporation: Recent Developments
Celgene Corporation: News and Events Summary
Celgene Corporation: Corporate Governance
Celgene Corporation: Financial Deals
Celgene Corporation: Financial Performance
Celgene Corporation: Regulatory and Legal Events
Celgene Corporation: Research & Development
Contact Us
About Datamonitor

List of Tables

Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 4: Celgene Corporation: Key Competitors
Table 5: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celgene Corporation: M&A Activity by Geography (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2008 - YTD*2012)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2008 - 2012YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2008 - YTD*2012)
Table 14: Celgene Corporation: M&A Activity by Geography (2008 - YTD*2012)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2008 - YTD*2012)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2008 - YTD*2012)
Table 17: Celgene Corporation: Partnership Volume and Value Trend (2008 - YTD*2012)
Table 18: Celgene Corporation: Partnership Trend by Deal Type (2008 - YTD*2012)
Table 19: Celgene Corporation: Divestments Volume and Value Trend (2008 - YTD*2012)
Table 20: Celgene Corporation: Divestments by Geography (2008 - YTD*2012)
Table 21: Celgene Corporation: News and Events Summary
Table 22: Celgene Corporation: Corporate Governance
Table 23: Celgene Corporation: Financial Deals
Table 24: Celgene Corporation: Financial Performance
Table 25: Celgene Corporation: Regulatory and Legal Events

Full Table of Contents is available at:

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact